Area of research
Genetics · Radiology, Nuclear Medicine and Imaging
Research interest
Research interests include Medicine, Internal medicine, Ulcerative colitis, Placebo, Gastroenterology, and Antibody.
P0063 Colonic imaging mass cytometry and tissue transcriptomics reveal B cell and plasma cell modulation as a key immune feature of response to the anti-integrin therapy etrolizumab in ulcerative colitis
Engineering a protease-stable, oral single-domain antibody to inhibit IL-23 signaling
Gut Microbial Species and Endotypes Associate with Remission in Ulcerative Colitis Patients Treated with Anti-TNF or Anti-integrin Therapy
A Randomized Phase II Study of Efmarodocokin Alfa, an interleukin-22 Agonist, Versus Vedolizumab in Patients With Ulcerative Colitis
Local Pentraxin-2 Deficit Is a Feature of Intestinal Fibrosis in Crohn’s Disease
Dual targeting of lymphocyte homing and retention through α4β7 and αEβ7 inhibition in inflammatory bowel disease
Phase I study of the anti-FcRH5 antibody-drug conjugate DFRF4539A in relapsed or refractory multiple myeloma
Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of RG7667, a Combination Monoclonal Antibody, for Prevention of Cytomegalovirus Infection in High-Risk Kidney Transplant Recipients
A Phase II study of the efficacy and safety of rontalizumab (rhuMAb interferon-α) in patients with systemic lupus erythematosus (ROSE)